Thermo Fisher Scientific, Inc. engages in the provision ... Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents ...

With a market cap of $205.5 billion, Thermo Fisher Scientific Inc. (TMO) is a global leader in serving science, providing a ...

Lyndra secured $101m in Series E financing to advance its pipeline of long-lasting oral therapy products. "Lyndra and Thermo ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Assenagon Asset Management S.A. cut its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 61.6% ...

We came across a bullish thesis on Thermo Fisher Scientific Inc. (TMO) on Rijnberk InvestInsights’ Substack by Daan Rijnberk.

Brookstone Capital Management cut its stake in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 8.9% in the fourth ...

As Lyndra Therapeutics works to advance long-acting oral drugs for a range of diseases, the Massachusetts-based biotech is ...

UK Biobank Pharma Proteomics Project aims to create a comprehensive map of disease-associated protein levels in the human body to advance biomarker discovery Thermo Fisher Scientific Inc. (NYSE ...

Thermo Fisher Scientific Inc (NYSE ... spanning Life Sciences Solutions (LSS), Laboratory Products and Services (LPS), and other segments, has helped maintain its strong market position.

Thermo Fisher Scientific Inc. (NYSE: TMO ... We are not an agent for these third parties nor do we endorse or guarantee their ...